Targeted delivery across the blood-brain barrier (Q36316725)

13 August 2017

1 reference

title

Targeted delivery across the blood-brain barrier (English)

1 reference

13 August 2017

1 reference

Pieter J Gaillard

1

1 reference

13 August 2017

Corine C Visser

series ordinal

2

1 reference

13 August 2017

Albertus G de Boer

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

Expert Opinion on Drug Delivery

13 August 2017

1 reference

13 August 2017

2

1 reference

13 August 2017

2

1 reference

13 August 2017

299-309

1 reference

Drug and gene delivery to the brain: the vascular route

13 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Blood-brain barrier biology and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Junctions between intimately apposed cell membranes in the vertebrate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Fine structural localization of a blood-brain barrier to exogenous peroxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

γ-Glutamyl Transpeptidase in Isolated Brain Endothelial Cells: Induction by Glial Cells in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Cholecystokinin-immunoreactive neurons in rat and monkey cerebral cortex make symmetric synapses and have intimate associations with blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Role of the CNS microvascular pericyte in the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

The role of drug transporters at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Delivery of peptides and proteins through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Ultracytochemical characterization of anionic sites in the wall of brain capillaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Blood-brain barrier transport of a novel micro 1-specific opioid peptide, H-Tyr-D-Arg-Phe-beta-Ala-OH (TAPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Transporting therapeutics across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Transporter-mediated permeation of drugs across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Blood-brain barrier transcytosis of insulin in developing rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Transferrin and transferrin receptor function in brain barrier systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Human blood-brain barrier transferrin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Human blood-brain barrier insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Expression of P-glycoprotein (ABCB1) and Mrp1 (ABCC1) in adult rat brain: focus on astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Blood-brain barrier drug targeting: the future of brain drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

A study of intrathecal, cerebrospinal fluid-to-brain exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Drug targeting. Breaking down barriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Regulated portals of entry into the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Caveolae: an alternative membrane transport compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

The transferrin receptor: role in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Rapid transferrin efflux from brain to blood across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Absence of toxicity of chronic weekly intravenous gene therapy with pegylated immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Characterization and modulation of the transferrin receptor on brain capillary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Receptor mediated uptake of peptides that bind the human transferrin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

LRP: a multifunctional scavenger and signaling receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

LRP: a bright beacon at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

LRP: role in vascular wall integrity and protection from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

High transcytosis of melanotransferrin (P97) across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Regulation of plasminogen activation: a role for melanotransferrin (p97) in cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Regional distribution of heparin-binding epidermal growth factor-like growth factor mRNA and protein in adult rat forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Transgenic mice expressing the diphtheria toxin receptor are sensitive to the toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

Blood-brain barrier transport of 125I-labeled basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.2.299

21 January 2018

Identifiers

DOI

10.1517/17425247.2.2.299

1 reference

13 August 2017

1 reference